NCT07072403View on ClinicalTrials.gov

Trametinib Treatment for Complicated Vascular Anomalies

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

September 1, 2027

Conditions

Vascular Anomalies

Interventions

DRUG

Trametinib tablet

Drug is supplied in 0.5 mg and 2 mg tablets

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

West China Hospital

OTHER